查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722975

2025 年至 2033 年基因检测市场规模、份额、趋势及预测（按类型、技术、应用和地区）

Genetic Testing Market Size, Share, Trends and Forecast by Type, Technology, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球基因检测市场规模价值 195 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 448.8 亿美元，2025 年至 2033 年的复合年增长率为 9.70%。北美目前占据市场主导地位，2024 年的市占率将超过 45.6%。北美市场主要受到技术进步、个人化医疗需求不断增长、遗传疾病患病率上升、政府支持倡议的出台以及道德、法律和社会考虑因素日益增加的影响。

基因检测市场分析：

市场成长与规模：随着大众了解程度的提高和对个人化医疗的需求增加，该产业正在强劲成长。随着检测技术的进步，市场正以极快的速度渗透到新的医疗保健领域，并已成为医疗保健行业最具活力的领域之一。

主要市场驱动因素：主要因素是新技术的引入、遗传疾病和慢性病盛行率的增加以及消费者对遗传风险认识的提高。政府对基因研究的倡议和资助也极大地帮助了该行业的市场成长，这为基因检测市场有多大提供了准确的答案。

技术进步：NGS（下一代定序）和 CRISPR 技术的创新彻底改变了测试，提供了精确且经济实惠的方法。这些发展扩大了基因检测的范围和机会，进而增加了其在临床和研究中的使用。

产业应用：检测应用包括癌症诊断、遗传疾病诊断、心血管疾病诊断等。它可用于诊断和管理遗传疾病，使其成为现代医疗保健不可分割的一部分。

主要市场趋势：人们越来越倾向于直接面向消费者的服务，使用者无需医生介入即可获取基因资讯。市场也正在经历一种趋势，即检测正在成为疾病筛检和管理的常规医疗保健实践的一部分，这表明基因检测市场的未来前景乐观。

地理趋势：北美占据市场主导地位，其次是欧洲和亚太地区。医疗设施、人均医疗支出、政府援助等因素也促进了这些地区的发展。儘管面临当前挑战，拉丁美洲、中东和非洲的新兴市场仍展现出成长潜力。

竞争格局：市场竞争激烈，主要参与者从事研发、策略伙伴关係和法规遵循。这些公司正专注于扩大其测试组合併探索新的市场机会以保持其竞争优势。

挑战与机会：虽然市场提供了巨大的成长机会，但也面临着测试的道德和法律影响、对熟练专业人员的需求以及公众认知问题等挑战。应对这些挑战并利用技术进步为市场扩张和创新提供了重大机会。

基因检测市场趋势：

基因检测技术的进步

基因检测技术的进步对推动基因检测市场规模的成长起到了重要作用。这些技术创新带来了更准确、更有效率、更具成本效益的基因分析方法，将检测范围扩展到肿瘤学、药物基因组学和预测测试等领域，进一步推动了基因检测市场的成长。增强型定序技术，例如次世代定序 (NGS)，可以提供有关遗传疾病的详细见解，从而实现早期发现和个人化治疗计划。例如，

一项针对 1914 名女性的研究表明，与标准筛检相比，cfDNA 检测显着降低了 21 三体和 18 三体的假阳性率，检测非整倍体的成功率为 100%，且预测值更高。此外，简化的流程增加了各种医疗保健环境中对基因检测的采用，从而促进了基因检测市场的需求。

个人化医疗意识和需求不断增强

人们对个人化医疗的认识和需求不断提高，也在塑造基因检测市场前景方面发挥了重要作用。个人化医疗依赖基因资讯来制定治疗方案，这增加了对基因检测的需求。这种需求在肿瘤学和生殖健康等领域尤其明显，这些领域的基因检测可以指导治疗决策并评估后代的遗传疾病风险。例如，根据一项研究，一项回覆率为 36% 的调查显示，在 312 名受访者中，83% 的人对直接面向消费者的基因检测有极少的询问，14% 的人涉及结果解释，超过 50% 的人支持遗传咨询师和临床环境进行基因检测的作用，70% 的人愿意为有匿名检测或访问问题的患者。此外，消费者对了解健康状况的遗传倾向的兴趣日益浓厚，进一步推动了基因检测市场概况，推动了基因检测市场统计数据和基因检测市场趋势。

遗传性疾病和慢性病增多

全球遗传疾病和慢性病的增加进一步推高了基因检测市场的数据。基因检测在囊性纤维化、镰状细胞性贫血和亨廷顿氏病等各种疾病的早期发现、诊断和管理中发挥着至关重要的作用。此外，随着癌症、心血管疾病和糖尿病等慢性疾病发生率的不断上升，人们越来越需要进行检测，以识别导致个人患有这些疾病的基因突变。世界卫生组织 (WHO) 报告称，癌症、心血管疾病和糖尿病等非传染性疾病 (NCD) 每年造成全球 73% 的死亡。基因检测可以帮助识别患有这些疾病的风险个体。透过检测进行早期发现可以改善患者的治疗效果，进一步推动基因检测市场的发展。基因检测市场规模庞大，美国等已开发国家每年的基因检测数量都有显着成长。展望未来，基因检测前景光明，预计持续的技术进步将提高准确性和可及性。怀孕期间的基因检测也变得越来越普遍，为胎儿健康和遗传状况提供了宝贵的见解。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球基因检测市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 预测性和症状前检测
  • 携带者检测
  • 产前和新生儿检测
  • 诊断测试
  • 药物基因组学检测
  • 其他的

第七章：市场区隔：依技术

  • 细胞遗传学检测和染色体分析
  • 生化检测
  • 分子检测
    • 关键部分
      • DNA定序
      • 其他的

第 8 章：市场区隔：按应用

  • 癌症诊断
  • 遗传疾病诊断
  • 心血管疾病诊断
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 23andme Inc.
    • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
    • Bio-RAD Laboratories Inc.
    • Cepheid (Danaher Corporation)
    • Eurofins Scientific
    • Illumina Inc.
    • Invitae Corporation
    • Luminex Corporation (DiaSorin)
    • Myriad Genetics Inc.
    • QIAGEN
    • Quest Diagnostics
    • Thermo Fisher Scientific
Product Code: SR112025A5788

The global genetic testing market size was valued at USD 19.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 44.88 Billion by 2033, exhibiting a CAGR of 9.70% from 2025-2033. North America currently dominates the market, holding a market share of over 45.6% in 2024. The North American market is primarily driven by technological advancements, escalating demand for personalized medicine, rising prevalence of genetic disorders, introduction of supportive government initiatives, and increasing implication of ethical, legal, and social considerations.

Genetic Testing Market Analysis:

Market Growth and Size: The sector is seeing strong growth as the public becomes more informed and the appetite for personalized medicine increases. With advancements in testing technologies, the market is penetrating new healthcare sectors at an extremely rapid pace and has become one of the most dynamic segments of the healthcare industry.

Major Market Drivers: The main factors are the introduction of new technologies, the increase in the prevalence of genetic diseases and chronic conditions and the increasing of the consumer's knowledge about genetic risks. Government initiatives and funding of genetic research also greatly assist the industry in market growth, which provide an accurate answer to how big is the genetic testing market.

Technological Advancements: Innovations in NGS (next-generation sequencing) and CRISPR technologies have revolutionized testing providing precise and budget-friendly methods. These developments have enlarged the range and opportunity of genetic testing, which in turn has increased the usage of it both in clinical settings and in research.

Industry Applications: The application of the testing includes cancer diagnosis, genetic disease diagnosis, and cardiovascular disease diagnosis. It can be used for diagnosing and managing genetic diseases makes it an inseparable part of modern healthcare.

Key Market Trends: There is a rising preference for direct-to-consumer services, in which users can acquire genetic information without using an intervening doctor. The market is also experiencing a trend where testing is becoming part of regular healthcare practices for disease screening and management, which indicates a positive outlook for the future of genetic testing market.

Geographical Trends: North America dominates the market, followed by Europe and the Asia Pacific. Factors including healthcare facilities, per capita medical expenditure, and governmental assistance also contribute to the development of these regions. Emerging markets in Latin America and the Middle East and Africa show potential for growth despite current challenges.

Competitive Landscape: The market is highly competitive with key players engaging in research and development, strategic partnerships, and regulatory compliance. These companies are focusing on expanding their testing portfolios and exploring new market opportunities to maintain their competitive edge.

Challenges and Opportunities: While the market offers substantial growth opportunities, it faces challenges such as ethical and legal implications of testing, the need for skilled professionals, and public perception issues. Addressing these challenges and harnessing technological advancements present significant opportunities for market expansion and innovation.

Genetic Testing Market Trends:

Advancements in genetic testing technologies

Advancements in genetic testing technologies have been instrumental in driving the genetic testing market size. These technological innovations have led to more accurate, efficient, and cost-effective genetic analysis methods, expanding the scope of testing into areas such as oncology, pharmacogenomics, and predictive testing, further driving the genetic testing market growth. Enhanced sequencing techniques, such as next-generation sequencing (NGS), provide detailed insights into genetic disorders, enabling early detection and personalized treatment plans. For instance,

A study on 1914 women revealed cfDNA testing significantly reduces false positives for trisomies 21 and 18 compared to standard screening, with a 100% success rate in detecting aneuploidies and higher predictive values. Furthermore, simplified processes have increased the adoption of genetic testing across various healthcare settings, contributing to the genetic testing market demand.

Increasing awareness and demand for personalized medicine

Increasing awareness and demand for personalized medicine have also played a significant role in shaping the genetic testing market outlook. Personalized medicine, which relies on genetic information to tailor treatments, has heightened the demand for genetic tests. This demand is particularly evident in sectors such as oncology and reproductive health, where genetic testing guides therapy decisions and assesses genetic disorder risks in offspring. For example, according to a study, survey with a 36% response rate showed that 83% of the 312 respondents had minimal inquiries about direct-to-consumer genetic testing, 14% dealt with result interpretation, and over 50% supported the role of genetic counsellors and clinical settings for genetic testing, with 70% open to considering it for patients with privacy, anonymity, or access concerns. Additionally, growing consumer interest in understanding genetic predispositions to health conditions further fuels genetic testing market overview, driving genetic testing market statistics and genetic testing market trends.

Rise in genetic disorders and chronic diseases

The rise in genetic disorders and chronic diseases globally is further escalating the genetic testing market statistics. Genetic testing plays a vital role in the early detection, diagnosis, and management of various conditions such as cystic fibrosis, sickle cell anemia, and Huntington's disease. Moreover, with the increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, there is a heightened need for testing to identify genetic mutations predisposing individuals to these conditions. The World Health Organization (WHO) reports that non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, and diabetes, are responsible for 73% of global deaths annually. Genetic testing can help identify individuals at risk for these conditions. Early detection through testing improves patient outcomes, further propels the genetic testing market. The genetic testing market is substantial, with a considerable growth in the number of genetic testing per year in USA and other developed countries. Looking ahead, the future of genetic testing is promising, with continued technological advancements expected to enhance accuracy and accessibility. Genetic testing in pregnancy is also becoming increasingly prevalent, providing valuable insights into fetal health and genetic conditions.

Genetic Testing Industry Segmentation:

Breakup by Type:

  • Predictive and Presymptomatic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

Diagnostic testing accounts for the majority of the market share

The largest sector of the market is the diagnostic testing market, which is employed to reveal or confirm specific inherited disease in symptomatic people. This sector is on the rise due to its contribution to a precise diagnosis, which is necessary for appropriate treatment and control of a plethora of genetic conditions. The fact of its broad fields of using from rare genetical diseases till common conditions brings attention to this issue in medical sector. An investigation that appeared in the Journal of Molecular Diagnostics revealed that the percentage of medical professionals who had integrated genetic diagnostic testing for hereditary cancers definitely had grown from 19.8% in 2014 to 38.4% in 2018.

Breakup by Technology:

  • Cytogenetic Testing and Chromosome Analysis
  • Biochemical Testing
  • Molecular Testing
  • DNA Sequencing
  • Others

Molecular testing holds the largest share in the industry

Molecular testing represents the largest section in the market. The methodology portion cover PCR, NGS, and other filtered DNA related analysis terms. It is very practical as it can be applied for many sections, from detecting genetic changes that give rise to diseases, to exploring cancer genetics for the reason of targeted treatments, and to unearthing genetic predispositions for different conditions. The unique capability of molecular testing associated with the precision it offers has established the field of genetic diagnostics, individualized medicine, and research as a key area in molecular science, giving it a leading position in this field. A 2021 study evaluated various COVID-19 molecular tests, revealing a high sensitivity rate of 95.9% for minimizing false negatives, and a specificity rate of 97.2% to reduce false positives. Besides, cytogenetic testing, including chromosome analysis means looking through section of chromosome in attempted to get information about chromosomal abnormalities of the patient. This part has a vital role in recognition the chromosome count, missing only one chromosome could cause genetic disorders such as Down syndrome, Klinefelter syndrome or Turner syndrome. It is widely use in pre-natal testing, cancer diagnosis and also for studying cells chromosome change, which are hardly beyond disease.

The biochemical testing, on the other hand, is directed towards the measurement of the exact amount of activity in most cases of specific enzymes in the body or the levels of proteins, hormones and other substances that comprise the body. This segment is a vital step in identifying metabolic disorders that result from enzyme deficiency by determining conditions like PKU or Tay- Sachs Disease, as possible causes.

Breakup by Application:

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Others

Genetic disease diagnosis represents the leading market segment

Genetic testing is currently utilized to diagnose a large number of diseases that are affected by both single-gene and multiple-gene factors. Genetic disease diagnosis is essential for the early detection of diseases and prompt intervention that finally aid in the condition's management. This growth is powered by its rear-rooted importance in the field of medicine which is represented in the accurate diagnoses of the genetic diseases not only for treatment but also for family planning. Between 2012 and 2022, the US led in the expansion of genetic tests, primarily for clinical diagnosis, highlighting the need for mandatory reporting and international collaboration for a comprehensive understanding of global genetic testing.

Using genetic analysis for cancer diagnosis implies finding out genetic mutations or alterations which cause cancer to develop. This portion is very vital for early tumor detection, diagnosis and controlling different categories of cancer.

Moreover, the genetic diagnosis of cardiovascular diseases involves locating these genetic variants to establish an increased risk for such heart-related defects as congenital heart defects, various cardiomyopathies, and arrhythmias.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the world market, driven by the world class healthcare infrastructure, the high amount of money that is spent on the healthcare sector and the presence of top companies and research institutions. The region is propelled by strong private investment, in the field of personalized medicine, large investments by governments in gene research, and favorable policy decisions from the national government. Besides, genetic disorders as well as chronic diseases, with a growing number of patients and informed population ready to access testing services, boost propel this company's leading position in the market.

The European region remains of crucial importance in terms of the market structure which is based on well-developed healthcare systems and governmental financial support of genetic research. The locale's market growth is propelled by the growing awareness about genetic DNA, personalized medicine, and the availability of qualified personnel in the field of genetics.

The Asia Pacific region is experiencing a growing market come from the fact that it is a large population base, infrastructure on healthcare rising and increasing the expenditure on healthcare. The market also draws support from genetic disease awareness growth, personalized medicine demanded growth, and government initiatives in health care reform.

The Latin American market is developing steadily, it is stimulated by improvement of the healthcare infrastructure, by the growth of the wages, and by the increase in public health awareness. As region is faced with the increasing demand for testing services for diseases prevention, diagnosis, and treatment.

The middle east and Africa market holds a lot of promise of significant growth. Factors that include the rising number of healthcare expenditure, the growing prevalence of genetic diseases, as well as the heightened level of awareness of the significant effects of genetic testing across the industry are the major drivers of genetic testing in this part of the world.

Leading Key Players in the Genetic Testing Industry:

Market's key players adopt different strategies to achieve fundamental objective of strengthening their market share. This include is investing heavily in research and development to innovation and evolution of genetic testing technologies, especially in the direction of next-generation sequencing (NGS) and CRISPR. They also engage in the establishment of partnerships and collaboration with other biotech companies, academic institutions, as well as healthcare providers to help them grow in their services portfolio and geographical reach. Besides this, manufacturers are making efforts to get the new devices approved by the regulator agencies to be in compliance with regulations and guarantee the patient safety. Additionally, direct-to-consumer services have been developed with the aim of leveraging consumers' growing demand for personalized healthcare and genetic wellness.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • 23andme Inc.
  • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
  • Bio-RAD Laboratories Inc.
  • Cepheid (Danaher Corporation)
  • Eurofins Scientific
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation (DiaSorin)
  • Myriad Genetics Inc.
  • QIAGEN
  • Quest Diagnostics
  • Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

11 July 2023: Quest Diagnostics launched Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights. The new offering helps people understand their potential risk of developing certain inheritable health conditions, with advanced technology and end-to-end support that includes personalized health reports and access to genetic counseling.

14 April 2023: QIAGEN launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

10 March 2022: Thermo Fisher Scientific introduced latest generation of SeqStudio Flex Series Genetic Analyzer to enable customer's cutting-edge research in areas such as gene editing and infectious disease.

Key Questions Answered in This Report

  • 1.What is genetic testing?
  • 2.How big is the genetic testing market?
  • 3.What is the expected growth rate of the global genetic testing market during 2025-2033?
  • 4.What are the key factors driving the global genetic testing market?
  • 5.What is the leading segment of the global genetic testing market based on type?
  • 6.What is the leading segment of the global genetic testing market based on technology?
  • 7.What is the leading segment of the global genetic testing market based on application?
  • 8.What are the key regions in the global genetic testing market?
  • 9.Who are the key players/companies in the global genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Predictive and Presymptomatic Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Carrier Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Prenatal and Newborn Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pharmacogenomic Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cytogenetic Testing and Chromosome Analysis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biochemical Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 DNA Sequencing
      • 7.3.2.1 Others
    • 7.3.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disease Diagnosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 23andme Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cepheid (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Invitae Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Luminex Corporation (DiaSorin)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Myriad Genetics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Genetic Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Genetic Testing Industry: SWOT Analysis
  • Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
  • Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Genetic Testing Market: Competitive Structure
  • Table 7: Global: Genetic Testing Market: Key Players